United States · Wires & real time · PR Newswire

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Published by PR Newswire · United States 1 h ago

BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Associated Press (Business)

What to consider if a company that made AI-related job cuts wants you back

Dow Jones Newswires

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Share

Also worth reading

What to consider if a company that made AI-related job cuts wants you back

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows